Marker Therapeutics

MRKRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$18.674 M

$1.12 +0.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$12.2M

Loss-making

Shares outstanding

16,673,127

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#402NeuroSense TherapeuticsNRSN$18.9M
#403Citius PharmaceuticalsCTXR$18.7M
#404Marker TherapeuticsMRKR$18.7M
#405Skye BioscienceSKYE$18.3M
#406NewcelXNCEL$17.8M

Where these numbers come from

Share counts and financials for Marker Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.